VolitionRx Limited to Present at Conferences in March & April 2019
ISNES, Belgium, March 25, 2019…
CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009)
SUZHOU, China, March 21, 2019 …
Sanofi Chief Executive Officer Olivier Brandicourt attended the China Development Forum and spoke at the Economic Summit
-Showing commitment to help pr…
Exyte demonstrates high-potential digital Smart Fab Solution at SEMICON China 2019
SHANGHAI, March 22, 2019 /PRNe…
Concord Medical Announces New Appointments to Management Team
BEIJING, March 19, 2019 /PRNew…
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
– License and Collaborat…
